This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Jensen, L. O. Articles by Thuesen, L. Search for Related Content PubMed Articles by Jensen, L. O. Articles by Thuesen, L.

Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions

Lisette Okkels Jensen, MD, PhD^_*,_*, Michael Maeng, MD, PhD, Anne Kaltoft, MD, PhD, Per Thayssen, MD, DMSci^_*, Hans Henrik Tilsted Hansen, MD, Morten Bottcher, MD, PhD, Jens Flensted Lassen, MD, PhD, Lars Romer Krussel, MD, DMSci, Klaus Rasmussen, MD, DMSci^,, Knud Noerregaard Hansen, MD^_*, Lars Pedersen, MSc^||, Soeren Paaske Johnsen, MD, PhD^,||, Henrik Toft Soerensen, MD, DMSci, PhD^||,¶ and Leif Thuesen, MD, DMSci

^_* Department of Cardiology, Odense University Hospital, Odense, Denmark
Department of Cardiology, Skejby Sygehus University, Aarhus, Denmark
^|| Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
Center of Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
^¶ Department of Epidemiology, Boston University, Boston, Massachusetts.

View larger version (14K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Clinical Outcome (A) Definite stent thrombosis (ST). Risk of definite ST among patients treated with bare-metal stents (BMS) or drug-eluting stents (DES). (B) Overall ST. Risk of definite, probable, and possible ST among patients treated with BMS or DES. (C) All-cause mortality. All-cause mortality among patients treated with BMS or DES. (D) Myocardial infarction (MI). Risk of MI among patients treated with BMS or DES.